EKElisabeth Klupp

Elisabeth Klupp

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elisabeth Klupp has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Alexander Drzezga

    Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany

    1 shared publication
  • Behrooz H. Yousefi

    Technische Universität München Neuroimaging Center (TUM-NIC), Klinikum Rechts der Isar, Technische Universität München, Munich, Germany Pharmaceutical Radiochemistry, Technische Universität München, Garching, Germany

    1 shared publication
  • Christian Sorg

    Technische Universität München Neuroimaging Center (TUM-NIC), Klinikum Rechts der Isar, Technische Universität München, Munich, Germany Department of Neuroradiology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany; and

    1 shared publication
  • Igor Yakushev

    Department of Nuclear Medicine, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany Technische Universität München Neuroimaging Center (TUM-NIC), Klinikum Rechts der Isar, Technische Universität München, Munich, Germany

    1 shared publication
  • Masoud Tahmasian

    Research Center Jülich

    1 shared publication
  • Stefan Förster

    Department of Nuclear Medicine, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany Technische Universität München Neuroimaging Center (TUM-NIC), Klinikum Rechts der Isar, Technische Universität München, Munich, Germany

    1 shared publication

Latest Publications

  • Prefrontal Hypometabolism in Alzheimer Disease Is Related to Longitudinal Amyloid Accumulation in Remote Brain Regions

    by Elisabeth Klupp, Timo Grimmer, Masoud Tahmasian, Christian Sorg, Igor Yakushev, Behrooz H. Yousefi, Alexander Drzezga, Stefan Förster

    In PET studies of patients with Alzheimer disease (AD), prominent hypometabolism can occur in brain regions without major amyloid load. These hypometabolism-only (HO) areas may not be explained easily as a consequence of local amyloid toxicity. The aim of this longitudinal multimodal imaging study was the investigation of locoregional and remote relationships between metabolism in HO areas and longitudinal amyloid increase in functionally connected brain areas, with a particular focus on intrinsic functional connectivity as a relevant linking mechanism between pathology and dysfunction. Methods: Fifteen AD patients underwent longitudinal examinations with 11C-Pittsburgh compound B (11C-PiB) and 18F-FDG PET (mean follow-up period, 2 y). The peak HO region was identified by the subtraction of equally thresholded statistical T maps (hypometabolism minus amyloid burden), resulting from voxel-based statistical parametric mapping group comparisons between the AD patients and 15 healthy controls. Then functionally connected and nonconnected brain networks were identified by means of seed-based intrinsic functional connectivity analysis of the resting-state functional MRI data of healthy controls. Finally, network-based, region-of-interest–based, and voxel-based correlations were calculated between longitudinal changes of normalized 11C-PiB binding and 18F-FDG metabolism. Results: Positive voxel-based and region-of-interest–based correlations were demonstrated between longitudinal 11C-PiB increases in the HO-connected network, encompassing bilateral temporoparietal and frontal brain regions, and metabolic changes in the peak HO region as well as locoregionally within several AD-typical brain regions. Conclusion: Our results indicate that in AD amyloid accumulation in remote but functionally connected brain regions may significantly contribute to longitudinally evolving hypometabolism in brain regions not strongly affected by local amyloid pathology, supporting the amyloid- and network-degeneration hypothesis.